Neuronetics holder reports 6,985,404 shares stake
Neuronetics, Inc. reported that significant shareholder Jorey Chernett beneficially owns 6,985,404 shares of the company’s common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Neuronetics, Inc. reported that significant shareholder Jorey Chernett beneficially owns 6,985,404 shares of the company’s common stock. This Form 3 filing is an initial statement of holdings by a more than ten percent owner and does not reflect any new share transactions.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Common Stock, $0.01 Par Value | -- | -- | -- |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does Jorey Chernett’s Form 3 filing for Neuronetics (STIM) show?
Is Jorey Chernett a director or officer of Neuronetics (STIM)?
Does the Neuronetics (STIM) Form 3 indicate any recent insider trades?
Why is Jorey Chernett required to file a Form 3 for Neuronetics (STIM)?
AI-generated analysis. How Rhea-AI works. Not financial advice.